Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lamisil 1% cream
131002030BBAAAA
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 763 |
|
Lamisil Once 1% solution
131002030BBAEAD
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 169 |
|
Lamisil AT 1% spray
131002030BBACAB
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 111 |
|
Lamisil AT 1% cream
131002030BBABAA
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 41 |
|
Lamisil AT 1% gel
131002030BBADAC
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 20 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.